651 filings
Page 18 of 33
8-K
47bl wt8tj
8 Nov 12
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports
12:00am
8-K
3jrfb9zckk9o8t3w4w
2 Aug 12
OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial
12:00am
ARS
7vftmw ro
4 Jun 12
Annual report to shareholders
12:00am
8-K
ig6pm1 5vz0wdfnwejqo
1 Jun 12
Departure of Directors or Certain Officers
12:00am
8-K
ua24 41dq8ekwrd
3 May 12
OncoGenex Pharmaceuticals, Inc. Reports Financial Results and Reviews Clinical Development
12:00am
8-K
53mvim69hbjdsf1m7
23 Mar 12
OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment
12:00am
424B5
436ay04 w1wwxrs73la
16 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
99m0oo0
16 Mar 12
OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
12:00am
424B5
tyny2aos 1ddffbr
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
l5vt9u5lqac02qrgki3p
15 Mar 12
OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
12:00am
8-K
iiorz4hrf89
8 Mar 12
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End
12:00am
8-K
uekh8nx ovhkr7w
2 Feb 12
Clinical Data on OGX-427 Presented at the ASCO 2012 Genitourinary
12:00am
EFFECT
x5z4j3ab hun5db
21 Nov 11
Notice of effectiveness
12:00am
8-K
ua4juic 5hls14erq87z
3 Nov 11
OncoGenex Pharmaceuticals Reports Financial Results for Third Quarter 2011 and Highlights Advancement of Portfolio Compounds
12:00am